Company

Wave Life Sciences, Inc.

WVE · CIK 0001631574

SEC FORM 4

$67,183.00

Sale of 12,700 shares at $5.29 per share.

Reporting Person Rawcliffe Adrian · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001193125-26-349962 · filed 2026-08-13 · View filing →

SEC FORM 4

$2,596.32

Sale of 432 shares at $6.01 per share.

Reporting Person Tan Aik Na · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001193125-26-349960 · filed 2026-08-13 · View filing →

SEC FORM 4

$23,222.64

Sale of 3,864 shares at $6.01 per share.

Reporting Person TAKANASHI KEN · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001193125-26-349961 · filed 2026-08-13 · View filing →

SEC FORM 4

$41,790.00

Acquisition (code M) of 7,000 shares at $5.97 per share.

Reporting Person Wagner Heidi L · Transaction Code M

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001193125-26-349963 · filed 2026-08-13 · View filing →

SEC FORM 4

$42,070.00

Sale of 7,000 shares at $6.01 per share.

Reporting Person Wagner Heidi L · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001193125-26-349963 · filed 2026-08-13 · View filing →